Skip to main content

March 2023

 

Requests that are not applicable to the Trust or those that have been transferred out are listed below;

CORP 2023 - 043               Emergency Department Floor Plans

CORP 2023 - 047               3D printing technology

CORP 2023 – 048              Palantir Technologies

CORP 2023 – 045              Contract Register

 

CORP 2023 - 040 DATIX Statistics and reports
CORP 2023 - 038 – Patient Discharge Data
CORP 2023 - 039 – Number of Clinical trials that have taken place in 20222 across the Trust
CORP 2023 - 041 – Treatment for Myelofibrosis
CORP 2023 - 042 – Incidence and Treatment of Oesophageal and Gastric Cancer
CORP 2023 - 044 – H.Pylori Testing
CORP 2023 - 046 Incidence and treatment of Urothelial and Colorectal Cancer
CORP 2023 - 049 – Subject Access Requests Process
CORP 2023 - 049 – Subject Access Requests Process (attachment)
CORP 2023 - 050 – Patient Level Costing System and Integrated Data Platform (for secondary use)
CORP 2023 - 051 – Information systems
CORP 2023 - 051 – Information systems (attachment)
CORP 2023 - 052 – Digital Communication with Patients
CORP 2023 - 052 – CORP 2023 - 052 – Digital Communication with Patients (attachment)
CORP 2023 - 053 – Agency usage in the Sonography/Ultrasound department
CORP 2023 - 054 – Medical Rostering
CORP 2023 - 055 – Screening & Immunisation staff
CORP 2023 - 056.– Medical Equipment for Home Use
CORP 2023 - 057 – Treatment with Nivolumab
CORP 2023 - 058 – Treatment with Dabrafenib & Trametinib